Healthcare Market Reports

Earwax removal aids are the medical tools used to remove earwax caused due to excessive formation of cerumen. The earwax removal aid includes micro-suction device, earwax removal irrigation kits, earwax removal drops, earwax removal loops, earwax removal syringes, and portable ear cleaning devices. According to the Fact.MR report, retail sales, especially in developing regions, is projected to show remarkable growth, due to easy availability of over-the-counter earwax removal aids. Request Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=4100 The healthcare industry is consistently witnessing an uplift in the number of ENT surgeries every year, globally, due to rising prevalence of ENT-related disorder. Around 3-5% of ear disorders is because of earwax impaction. It is also due to the adoption of improper treatment method with self-analysis by the individual with earwax impaction. The traditional practices increase the disease morbidity, and at a certain ...

According to a new study of FactMR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment. There has been a significant rise in the prevalence of gonorrhea that is resistant to components of dual antibiotic therapy – ceftriaxone and azithromycin, which is the only recommended treatment for gonorrhea. In addition, resistance to several other antibiotics apart from dual antibiotic therapy resulted in ‘super gonorrhea’, which has become a buzzword in the gonorrhea therapeutics market . With a slew of promising new antibiotics on the horizon, alongside surveillance, education and preventative measures to stymie prevalence of super-resistant gonorrhea, prospects seem bullish for the gonorrhea therapeutics market. Request S...

According to a new study of FactMR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment. There has been a significant rise in the prevalence of gonorrhea that is resistant to components of dual antibiotic therapy – ceftriaxone and azithromycin, which is the only recommended treatment for gonorrhea. In addition, resistance to several other antibiotics apart from dual antibiotic therapy resulted in ‘super gonorrhea’, which has become a buzzword in the gonorrhea therapeutics market . With a slew of promising new antibiotics on the horizon, alongside surveillance, education and preventative measures to stymie prevalence of super-resistant gonorrhea, prospects seem bullish for the gonorrhea therapeutics market. Reque...